Global Market For Contraceptives Expected To Increase To Nearly $13.5 Billion In 2015
June 04, 2010
Wellesley, Mass. – According to a new technical market research report, CONTRACEPTIVES: TECHNOLOGIES AND GLOBAL MARKETS (HLC085A) from BCC Research (www.bccresearch.com), the value of the global market for contraceptives is an estimated $10.7 billion in 2010, but is expected to increase to nearly $13.5 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 4.8%.
The largest segment of the market, made up of hormonal contraceptives, is projected to increase at a CAGR of 2.8%, rising to more than $9.4 billion in 2015, after being valued at nearly $8.2 billion in 2010.
The second-largest segment, made up of barrier contraceptives, is estimated at more than $2.3 billion in 2010, and is expected to increase at a 5-year CAGR of 8.5% to reach more than $3.5 billion in 2015.
The “Others” segment (transcervical sterilization) is expected to reach more than $564 million in 2015, after rising at a CAGR of 27.1% from its 2010 value of $170 million.
This study was conducted to provide an update of new developments in the market of contraception technology and to provide detailed market analysis of contraceptive products along with the factors affecting this market. This industry was influenced by the economic downturn, but unlike other industries it was affected in a positive way. The advancements and the need for better and safer contraception methods have always influenced market growth. This study analyzes almost all the systems affected by these factors.
The contraceptive market is mature. Since the introduction of the birth control pill in 1960, the market has evolved and major changes have been implemented in order to make the product safe and easy to use, which involved dose reductions, different phasing regimens of the hormones used and also the development of new progestins. A detailed analysis of the contraceptive industry structure has been conducted, which includes the manufacturing of various types of contraceptives. Revenues are broken down by region. Sales figures are estimated for the 5–year period from 2010 through 2015.
Prevalence of contraceptive methods are also discussed separately in the report, with an explanation of the decreased use in some countries. The report also covers significant patents and their allotments in each category.
Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest.
Source: BCC Research
Contraceptives: Technologies and Global Markets( HLC085A )
Publish Date: May 2010
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49 Walnut Park, Building 2, Wellesley, MA 02481, Telephone: 866-285-7215; Email: email@example.com as the source and publisher. Thank you.